http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108324921-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-481 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108324921-B |
| titleOfInvention | A pharmaceutical composition with cyst removing and gastric mucosa protecting effects, and its preparation method |
| abstract | The invention relates to a pharmaceutical composition with functions of removing cysts and protecting gastric mucosa and a preparation method thereof, wherein the pharmaceutical composition comprises, by weight, 2-10 parts of propolis, 8-13 parts of pseudo-ginseng, 27-44 parts of astragalus membranaceus, 18-36 parts of rhizoma bletillae, 3-8 parts of oyster peptide, 5-12 parts of radix scrophulariae and 4-10 parts of potentilla discolor. The pharmaceutical composition of the invention, in which the pseudo-ginseng and the bletilla striata are monarch drugs, has the effects of dissipating blood stasis, stopping bleeding, reducing swelling, promoting granulation, eliminating sores, detoxifying and protecting gastric mucosa; the astragalus and the propolis are ministerial drugs, the astragalus can tonify qi, raise yang, induce diuresis to alleviate edema, expel toxin and discharge pus, and the propolis can detoxify, alleviate edema, astringe and promote tissue regeneration; radix scrophulariae and herba Potentillae Discoloris are adjuvant drugs, radix scrophulariae has effects of clearing heat and cooling blood, removing toxic substance and resolving hard mass, and herba Potentillae Discoloris has effects of clearing heat and removing toxic substance, stopping dysentery and hemostasis, detumescence and eliminating sore. The specially added oyster peptide can supply nutrient substances to the body, enhance the immunity and protect the gastric mucosa. The invention reasonably mixes the dosages of the components, leads the medicines of the components to be synergistic, and fully exerts the effects of removing cyst and protecting gastric mucosa. |
| priorityDate | 2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 117.